Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Grassy

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
FEBS Letters|February 19, 1998
Oligomerization of protegrin-1 in the presence of DPC micelles. A proton high-resolution NMR studyC Roumestand, V Louis, A Aumelas, et al.
Journal of Molecular Graphics & Modelling|June 7, 2000
Peptides quantitative structure-function relationships: an automated mutation strategy to design peptides and pseudopeptides from substitution matricesM Adenot, C Sarrauste de Menthière, A Chavanieu, et al.
European Journal of Biochemistry|May 13, 1998
Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micellesE Vignal, A Chavanieu, P Roch, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1989
[Hydroxyiminoacetone-like reactivators of phosphorylated cholinesterases. Structure-activity relationships via molecular modelling]M Bonnafous, J L Stigliani, Y Adam, et al.
Molecular Pharmacology|January 1, 1988
The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?G Meunier, D De Montauzon, J Bernadou, et al.
Journal of Molecular Biology|December 16, 1994
Investigating the high affinity and low sequence specificity of calmodulin binding to its targetsM Afshar, L S Caves, L Guimard, et al.
European Journal of Biochemistry|May 1, 1996
Synthesis and solution structure of the antimicrobial peptide protegrin-1A Aumelas, M Mangoni, C Roumestand, et al.
Nature Biotechnology|August 14, 1998
Computer-assisted rational design of immunosuppressive compoundsG Grassy, B Calas, A Yasri, et al.
FEBS Letters|March 25, 1996
Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formationM E Mangoni, A Aumelas, P Charnet, et al.
The Journal of Endocrinology|March 8, 2005
Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogueG Uçkaya, P Delagrange, A Chavanieu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
FEBS Letters|February 19, 1998
Oligomerization of protegrin-1 in the presence of DPC micelles. A proton high-resolution NMR studyC Roumestand, V Louis, A Aumelas, et al.
Journal of Molecular Graphics & Modelling|June 7, 2000
Peptides quantitative structure-function relationships: an automated mutation strategy to design peptides and pseudopeptides from substitution matricesM Adenot, C Sarrauste de Menthière, A Chavanieu, et al.
European Journal of Biochemistry|May 13, 1998
Solution structure of the antimicrobial peptide ranalexin and a study of its interaction with perdeuterated dodecylphosphocholine micellesE Vignal, A Chavanieu, P Roch, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 1, 1989
[Hydroxyiminoacetone-like reactivators of phosphorylated cholinesterases. Structure-activity relationships via molecular modelling]M Bonnafous, J L Stigliani, Y Adam, et al.
Molecular Pharmacology|January 1, 1988
The biooxidation of cytotoxic ellipticine derivatives: a key to structure-activity relationship studies?G Meunier, D De Montauzon, J Bernadou, et al.
Journal of Molecular Biology|December 16, 1994
Investigating the high affinity and low sequence specificity of calmodulin binding to its targetsM Afshar, L S Caves, L Guimard, et al.
European Journal of Biochemistry|May 1, 1996
Synthesis and solution structure of the antimicrobial peptide protegrin-1A Aumelas, M Mangoni, C Roumestand, et al.
Nature Biotechnology|August 14, 1998
Computer-assisted rational design of immunosuppressive compoundsG Grassy, B Calas, A Yasri, et al.
FEBS Letters|March 25, 1996
Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formationM E Mangoni, A Aumelas, P Charnet, et al.
The Journal of Endocrinology|March 8, 2005
Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S 23521, a new glucagon-like peptide 1 (GLP-1) analogueG Uçkaya, P Delagrange, A Chavanieu, et al.
Pageof 3